Jon Boyce was raised in Baton Rouge, Louisiana. After a short stay at Centenary College, he transferred to the University of California at Berkeley where he received his BS in chemistry under the direction of Dean Toste. Following two internships at Pfizer and Roche, Jon became a Visiting Researcher in Scott Snyder’s lab at Columbia University and pursued a PhD in synthetic chemistry at Boston University under the direction of John Porco. In his graduate studies, Jon developed efficient methods to access type A and B polycyclic polyprenylated acylphloroglucinol (PPAP) natural products and related analogs. As a TL1 PRECIENT and Cardiovascular Research Institute (CVRI) postdoctoral fellow at the University of California at San Francisco, Jon developed protease-activated antibiotic prodrugs in the labs of Ian Seiple, Bill DeGrado, and Charles Craik. Jon started his independent lab in the College of Pharmacy at The Ohio State University. Jon’s lab is interested in developing highly specific prodrugs for cancer and infectious diseases.